Davis A., Bates M., Koffman R., et al. “The Epidemiology of Psychedelic Use Among United States Military Veterans.” Journal of Psychoactive Drugs, Sep 2024.
Authors
Alan Davis, PhD; Mark Bates, PhD; Erik Lund MS; Nathan Sepeda, BS; Adam Levin, MD; Stacey Armstrong, PhD; Robert Koffman, MD; Katinka Hooyer, PhD; and Rachel Yehuda, PhD.
Originally published in Journal of Psychoactive Drugs as The Epidemiology of Psychedelic Use Among United States Military Veterans.
Abstract
We sought to identify patterns of psychedelic use among United States military veterans, compare demographic variables and perspectives of those who did and did not report use, and characterize benefits and adverse outcomes associated with use. Respondents (N = 426) were recruited to complete an online cross-sectional survey. Approximately one-half (51%) reported using psychedelics. Most did so for healing/treatment (70%) and/or spiritual purposes (48%), and most (85%) reported benefiting from use. Those who used psychedelics reported they would be more likely to use VA services (p < .001, d = 0.64) and to return to the VA for care (p < .001, d = 0.79) if psychedelic therapy was offered. Almost two-thirds (59%) reported adverse outcomes associated with use. Equivalent proportions rated their psychedelic experiences as beneficial among those who did (89%) and did not (81%) report adverse outcomes. Fewer adverse outcomes were associated with being older, using psilocybin, feeling prepared and confident in the reasons for use, being in a comfortable setting, and being able to “trust, let go, and be open” (Rc = 0.77; p < .001). Psychedelics may offer benefits but may also lead to adverse outcomes without proper preparation and support. Future research should examine the utility of psychedelic-based approaches for veteran mental health care.
Published Date: September 12, 2024